|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.91 USD | +3.01% |
|
+3.15% | +1.77% |
| Capitalization | 15TCr 13TCr 12TCr 12TCr 22TCr 14,06100Cr 23TCr 1,43100Cr 56TCr 6,70700Cr 58TCr 57TCr 24,49100Cr | P/E ratio 2025 * |
18.6x | P/E ratio 2026 * | 16.8x |
|---|---|---|---|---|---|
| Enterprise value | 17TCr 14TCr 13TCr 13TCr 23TCr 15,22900Cr 25TCr 1,54900Cr 61TCr 7,26400Cr 63TCr 62TCr 26,52500Cr | EV / Sales 2025 * |
5.75x | EV / Sales 2026 * | 5.33x |
| Free-Float |
99.9% | Yield 2025 * |
2.66% | Yield 2026 * | 2.79% |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +0.42% | ||
| 1 week | +3.15% | ||
| Current month | +1.77% | ||
| 1 month | +5.16% | ||
| 3 months | +5.99% | ||
| 6 months | +13.71% | ||
| Current year | +1.77% |
| 1 week | 119.63 | 125.12 | |
| 1 month | 116.88 | 127.41 | |
| Current year | 116.88 | 125.12 | |
| 1 year | 91.84 | 128.7 | |
| 3 years | 62.07 | 128.7 | |
| 5 years | 57.16 | 128.7 | |
| 10 years | 56.56 | 128.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 60 | 01/03/2019 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 01/11/2019 |
Dietmar Berger
CTO | Chief Tech/Sci/R&D Officer | 64 | 02/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 19/08/2016 |
| Director/Board Member | 73 | 01/01/2018 | |
| Director/Board Member | 72 | 09/05/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.01% | +3.15% | +36.29% | +44.79% | 15TCr | ||
| +0.53% | -2.37% | +37.06% | +187.15% | 93TCr | ||
| -0.41% | +6.98% | +47.97% | +26.08% | 53TCr | ||
| -0.31% | -2.60% | +23.40% | +39.55% | 38TCr | ||
| +0.93% | +2.38% | +29.90% | +18.43% | 37TCr | ||
| +0.19% | -1.15% | +29.58% | +20.35% | 29TCr | ||
| -1.93% | -1.54% | +8.07% | -3.05% | 27TCr | ||
| +0.98% | +1.37% | +27.61% | +34.08% | 28TCr | ||
| +6.49% | +1.95% | -35.37% | -18.36% | 27TCr | ||
| +0.12% | +1.32% | +22.63% | +21.59% | 18TCr | ||
| Average | +0.70% | +0.95% | +22.72% | +37.06% | 36.46TCr | |
| Weighted average by Cap. | +0.59% | +0.62% | +26.96% | +63.07% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.92TCr 2.52TCr 2.34TCr 2.18TCr 4.06TCr 2,65100Cr 4.37TCr 27TCr 11TCr 1,26400Cr 11TCr 11TCr 4,61700Cr | 3.02TCr 2.6TCr 2.42TCr 2.25TCr 4.2TCr 2,73800Cr 4.52TCr 28TCr 11TCr 1,30600Cr 11TCr 11TCr 4,76800Cr |
| Net income | 804.67Cr 693.71Cr 645.79Cr 601.2Cr 1.12TCr 73TCr 1.2TCr 7.43TCr 2.93TCr 35TCr 3.02TCr 2.96TCr 1,27200Cr | 889.91Cr 767.19Cr 714.2Cr 664.89Cr 1.24TCr 81TCr 1.33TCr 8.22TCr 3.24TCr 39TCr 3.34TCr 3.27TCr 1,40600Cr |
| Net Debt | 1.29TCr 1.11TCr 1.03TCr 961.49Cr 1.79TCr 1,16800Cr 1.93TCr 12TCr 4.68TCr 56TCr 4.83TCr 4.73TCr 2,03400Cr | 575.5Cr 496.14Cr 461.86Cr 429.98Cr 800.57Cr 52TCr 861.34Cr 5.31TCr 2.09TCr 25TCr 2.16TCr 2.11TCr 91TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | 124.91 $ | +3.01% | 1,06,39,074 |
| 15/26/15 | 121.26 $ | -2.26% | 66,59,785 |
| 14/26/14 | 124.07 $ | +1.90% | 46,59,420 |
| 13/26/13 | 121.76 $ | -0.69% | 58,03,884 |
| 12/26/12 | 122.60 $ | +1.24% | 73,97,037 |
Delayed Quote Nasdaq, January 17, 2026 at 02:30 am IST
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















